{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:56:22Z","timestamp":1781650582535,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the clinical significance of the Aspartate Aminotransferase to Platelet Ratio Index (APRI) score and blood-count-derived inflammatory markers in patients with preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective study included pregnant women diagnosed with preeclampsia, gestational hypertension, and healthy controls. Demographic, perinatal, hematological, and biochemical parameters were analyzed. Inflammatory markers, including Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), Platelet-to-Lymphocyte Ratio (PLR), Systemic Immune-Inflammation Index (SII), and APRI score, were compared among the study groups. ROC analysis was performed to assess the diagnostic discriminatory performance of these markers in diagnosing preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The APRI score was significantly higher in the preeclampsia group compared to the control and gestational hypertension groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), suggesting potential hepatic involvement in preeclampsia. In contrast, no statistically significant differences were found among the groups for NLR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.106), MLR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.593), PLR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.319), and SII (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.247). Hematological and biochemical analysis revealed that AST, BUN, and creatinine levels were significantly elevated in the preeclampsia group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), consistent with hepatic and renal involvement. However, platelet counts and hemoglobin levels did not show significant differences among the groups. ROC analysis demonstrated that the APRI score had poor diagnostic discriminatory performance (AUC\u2009=\u20090.437,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.128), and similarly, other inflammatory markers, including NLR (AUC\u2009=\u20090.539), MLR (AUC\u2009=\u20090.554), PLR (AUC\u2009=\u20090.552), and SII (AUC\u2009=\u20090.507), also failed to exhibit significant diagnostic accuracy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although the APRI score was elevated in preeclamptic patients, ROC analysis indicated poor discriminatory performance, suggesting that APRI does not provide meaningful diagnostic accuracy when used alone. Further prospective studies with larger populations are needed to explore its potential role in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09062-9","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:04:15Z","timestamp":1776474255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the APRI score and blood-count-derived inflammatory markers in patients with preeclampsia"],"prefix":"10.1186","volume":"26","author":[{"given":"B\u00fc\u015fra \u00d6zt\u00fcrk","family":"Ta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1904-7282","authenticated-orcid":false,"given":"Cenk","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"B\u0131y\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Ula\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Ta\u015f\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"14","key":"9062_CR1","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","volume":"76","author":"CW Ives","year":"2020","unstructured":"Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;76(14):1690\u2013702.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"9062_CR2","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","volume":"77","author":"JM Roberts","year":"2021","unstructured":"Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L. Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension. 2021;77(5):1430\u201341.","journal-title":"Hypertension"},{"issue":"2s","key":"9062_CR3","doi-asserted-by":"publisher","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","volume":"226","author":"E Jung","year":"2022","unstructured":"Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, et al. The etiology of preeclampsia. Am J Obstet Gynecol. 2022;226(2s):S844\u201366.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"9062_CR4","doi-asserted-by":"publisher","first-page":"2144175","DOI":"10.1080\/01443615.2022.2144175","volume":"43","author":"D Ozkan","year":"2023","unstructured":"Ozkan D, Ibanoglu MC, Adar K, Ozkan M, Lutfi Tapisiz O, Engin-Ustun Y, et al. Efficacy of blood parameters in predicting the severity of gestational hypertension and preeclampsia. J Obstet Gynaecol. 2023;43(1):2144175.","journal-title":"J Obstet Gynaecol"},{"issue":"11","key":"9062_CR5","first-page":"704","volume":"27","author":"N Leybovitz-Haleluya","year":"2025","unstructured":"Leybovitz-Haleluya N, Yahav L, Saban A, Hershkovitz R, Weintraub AY, Eshkoli T. The Use of the Aspartate Aminotransferase-to-Platelet Ratio Index as a Predictor of Obstetrical and Neonatal Adverse Outcomes in Patients with Preeclampsia Toxemia. Isr Med Assoc J. 2025;27(11):704\u20138.","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"9062_CR6","doi-asserted-by":"publisher","first-page":"e70137","DOI":"10.1111\/aji.70137","volume":"94","author":"YL Yao","year":"2025","unstructured":"Yao YL, Xu Z, Xiao R, Li EH, Zhang YJ, Zhou LY, et al. Elevated Neutrophil, Lymphocyte, and Platelet Counts as Early Biomarkers of Preeclampsia Risk: A Retrospective Cohort Study. Am J Reprod Immunol. 2025;94(2):e70137.","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"9062_CR7","first-page":"e41051","volume":"15","author":"D Ozkan","year":"2023","unstructured":"Ozkan D, Tokgoz Cakir B, Polat Kamaci C, Ozkan M, Iskender C, Tapisiz O, et al. Is There a Predictable Cost-Benefit Ratio in Preeclampsia? Cureus. 2023;15(6):e41051.","journal-title":"Cureus"},{"issue":"25","key":"9062_CR8","doi-asserted-by":"publisher","first-page":"10137","DOI":"10.1080\/14767058.2022.2122036","volume":"35","author":"\u00d6G Eyisoy","year":"2022","unstructured":"Eyisoy \u00d6G, Ta\u015fdemir \u00dc, Eri\u00e7 \u00d6zdemir M, Eyisoy S, Kahramano\u011flu \u00d6, \u00d6\u00e7al A, et al. Aspartate aminotransferase to platelet ratio index (APRI) score: is it useful in patients with intrahepatic cholestasis of pregnancy? J Matern Fetal Neonatal Med. 2022;35(25):10137\u201342.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10","key":"9062_CR9","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.jhepr.2024.101171","volume":"6","author":"J Boeckmans","year":"2024","unstructured":"Boeckmans J, Michel M, Gieswinkel A, T\u00fcscher O, Konstantinides SV, K\u00f6nig J, et al. Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study. JHEP Rep. 2024;6(10):101171.","journal-title":"JHEP Rep"},{"issue":"2","key":"9062_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"key":"9062_CR11","doi-asserted-by":"crossref","unstructured":"Starlinger P, Ubl DS, Hackl H, Starlinger J, Nagorney DM, Smoot RL et al. Combined APRI\/ALBI score to predict mortality after hepatic resection. BJS Open. 2021;5(1).","DOI":"10.1093\/bjsopen\/zraa043"},{"issue":"6","key":"9062_CR12","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237\u201360.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"9062_CR13","doi-asserted-by":"publisher","first-page":"2524327","DOI":"10.1080\/10641955.2025.2524327","volume":"44","author":"\u015e Karag\u00fcn","year":"2025","unstructured":"Karag\u00fcn \u015e, Y\u0131ld\u0131z H, Dal Y, Gamze Karaca S, Zeki Nessar A, \u00c7eviko\u011flu K\u0131ll\u0131 M, et al. Predictive value of 24-hour urine protein levels for adverse maternal and perinatal outcomes in hypertensive pregnancies. Hypertens Pregnancy. 2025;44(1):2524327.","journal-title":"Hypertens Pregnancy"},{"issue":"7","key":"9062_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124(7):1094\u2013112.","journal-title":"Circ Res"},{"key":"9062_CR15","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/JMDH.S459929","volume":"17","author":"Z Jamil","year":"2024","unstructured":"Jamil Z, Khalid S, Khan H, Waheed I, Ehsan A, Alissa M, et al. Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) as a Novel Score in Early Detection of Complicated Dengue Fever. J Multidiscip Healthc. 2024;17:2321\u201330.","journal-title":"J Multidiscip Healthc"},{"issue":"9","key":"9062_CR16","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1080\/14767058.2017.1410701","volume":"32","author":"D Mannaerts","year":"2019","unstructured":"Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil\/lymphocyte ratio (NLR), platelet\/lymphocyte ratio (PLR), and\/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J Matern Fetal Neonatal Med. 2019;32(9):1412\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"9062_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.5603\/GP.2016.0021","volume":"87","author":"C Gezer","year":"2016","unstructured":"Gezer C, Ekin A, Ertas IE, Ozeren M, Solmaz U, Mat E, et al. High first-trimester neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are indicators for early diagnosis of preeclampsia. Ginekol Pol. 2016;87(6):431\u20135.","journal-title":"Ginekol Pol"},{"key":"9062_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jri.2019.02.001","volume":"132","author":"J Wang","year":"2019","unstructured":"Wang J, Zhu QW, Cheng XY, Liu JY, Zhang LL, Tao YM, et al. Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia. J Reprod Immunol. 2019;132:29\u201334.","journal-title":"J Reprod Immunol"},{"issue":"51","key":"9062_CR19","doi-asserted-by":"publisher","first-page":"e18496","DOI":"10.1097\/MD.0000000000018496","volume":"98","author":"WF Zheng","year":"2019","unstructured":"Zheng WF, Zhan J, Chen A, Ma H, Yang H, Maharjan R. Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: A PRISMA-compliant systematic review and meta-analysis. Med (Baltim). 2019;98(51):e18496.","journal-title":"Med (Baltim)"},{"issue":"3","key":"9062_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.17772\/gp\/1713","volume":"85","author":"A Yavuzcan","year":"2014","unstructured":"Yavuzcan A, Ca\u011flar M, Ust\u00fcn Y, Dilbaz S, Ozdemir I, Yildiz E, et al. Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekol Pol. 2014;85(3):197\u2013203.","journal-title":"Ginekol Pol"},{"issue":"1","key":"9062_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/14767058.2014.905910","volume":"28","author":"E Kurtoglu","year":"2015","unstructured":"Kurtoglu E, Kokcu A, Celik H, Tosun M, Malatyalioglu E. May ratio of neutrophil to lymphocyte be useful in predicting the risk of developing preeclampsia? A pilot study. J Matern Fetal Neonatal Med. 2015;28(1):97\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"9062_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ajem.2019.02.014","volume":"38","author":"M \u015ea\u015fmaz","year":"2020","unstructured":"\u015ea\u015fmaz M, Ayvaz MA, D\u00fclger AC, Kuday Kayk\u0131s\u0131z EK, G\u00fcven R. Aspartate-aminotransferase to platelet ratio index score for predicting HELLP syndrome. Am J Emerg Med. 2020;38(3):459\u201362.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"9062_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.29271\/jcpsp.2021.02.188","volume":"31","author":"HE Tolunay","year":"2021","unstructured":"Tolunay HE, Kahraman NC, Varli EN, Reis YA, Celen S, Caglar AT. Can First-trimester AST to Platelet Ratio Index Scores Predict HELLP Syndrome? J Coll Physicians Surg Pak. 2021;31(2):188\u201392.","journal-title":"J Coll Physicians Surg Pak"},{"key":"9062_CR24","doi-asserted-by":"publisher","first-page":"101132","DOI":"10.1016\/j.preghy.2024.101132","volume":"37","author":"G \u0130pek","year":"2024","unstructured":"\u0130pek G, Tana\u00e7an A, A\u011fao\u011flu Z, G\u00fcl\u00e7in Ba\u015ftemur A, G\u00fclen Y\u0131ld\u0131z E, \u015eahin D. The role of aspartate aminotransferase to platelet ratio index (APRI) in the first trimester for the prediction of superimposed preeclampsia: A case-control study from a tertiary center. Pregnancy Hypertens. 2024;37:101132.","journal-title":"Pregnancy Hypertens"},{"key":"9062_CR25","unstructured":"Karag\u00fcn \u015e, Dal Y, Y\u0131ld\u0131z H, Nessar AZ, Karaca SG, Co\u015fkun A. Alanine aminotransferase to platelet ratio as a diagnostic tool for mild intrahepatic cholestasis of pregnancy. Perinat J. 2024;32(2)."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09062-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:19:04Z","timestamp":1781648344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09062-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9062"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09062-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as a retrospective case-control study at K\u00fctahya Health Sciences University, Evliya \u00c7elebi Training and Research Hospital. Ethical approval was obtained from the Non-Interventional Clinical Research Ethics Committee of K\u00fctahya Health Sciences University (Decision No: 2024\/02\u201303, Date: February 13, 2024). The study aimed to evaluate the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) score in patients with preeclampsia. The requirement for informed consent was waived by the ethics committee due to the retrospective design of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}